医生自制Endo-Bentall装置修复主动脉根部病变的早期结果与可行性
本研究报道了在高危主动脉根部病变患者中使用模块化瓣膜管道行血管内Bentall手术的早期经验。5例手术禁忌患者(平均79岁,4例A型夹层,1例根部动脉瘤)接受Endo-Bentall修复,装置植入成功率100%,院内死亡率0%,无术后卒中。随访CT未见1a型内漏,超声无主动脉瓣反流,提示该技术在高选择患者中可行有效,但需长期随访评估耐久性。
要点
- 医生自制Endo-Bentall装置由自膨胀TAVR、TEVAR及两个用于冠脉支架的钢丝加强开窗组成。
- 5例高危患者装置植入成功率100%,院内死亡率0%,无术后卒中。
- 随访中无1a型内漏和主动脉瓣反流,但需长期数据评估耐久性。
核心结论
- 使用单阶段带瓣管道的Endo-Bentall修复对于不适合手术的高度选择主动脉根部夹层或动脉瘤患者可行且有效,早期结果令人鼓舞。
- 需要长期随访数据评估密封持久性和该新技术的耐久性。
研究设计与样本
- 平均年龄79岁,4例为A型夹层,1例为主动脉根部动脉瘤;2例术前存在重度主动脉瓣反流。
主要发现
- Endo-Bentall装置植入成功率为100%(5/5)。
- 院内死亡率为0%,无患者发生术后卒中。
- 3例患者需要冠状动脉支架置入,1例需要永久起搏器植入。
- 随访CT(中位172天,范围63-368天)显示无患者存在1a型内漏。
- 随访经胸超声心动图显示无主动脉瓣反流。
关键数值与推荐
- 医生自制Endo-Bentall装置由自膨胀经导管主动脉瓣(TAVR)、胸主动脉腔内覆膜支架(TEVAR)及2个用于冠状动脉支架的钢丝加强开窗组成。
- TAVR瓣膜被缝合至合适尺寸的TEVAR移植物内,冠状动脉开窗基于CT血管造影测量在TEVAR移植物上制作。
- 装置重新装入TEVAR输送系统,经股动脉入路推进,在快速起搏下释放;若释放后存在持续内漏,则对冠状动脉开口行支架置入。
- 中位台面修改时间为120分钟(范围55-150分钟)。
- 2例患者需要同期全主动脉弓腔内修复。
临床怎么用
- 对于不适合开放手术的高危主动脉根部夹层或动脉瘤患者,可考虑使用医生自制Endo-Bentall装置进行血管内修复。
- 该技术无需心肺支持,经股动脉入路即可完成,但需要精确的CT血管造影测量和台面装置修改。
- 术后需密切随访CT和超声心动图,评估内漏、主动脉瓣反流及装置耐久性。
局限性
- 样本量小(5例),随访时间短(中位172天)。
- 为高度选择的患者群体,结果可能不适用于更广泛人群。
- 缺乏长期耐久性数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We present our experience with the endovascular Bentall procedure (Endo-Bentall) using a modular valve conduit in high-risk patients with aortic root pathologies. METHODS: The physician-constructed Endo-Bentall device is composed of a self-expanding transcatheter aortic valve (TAVR), thoracic endovascular aortic stent graft (TEVAR), and 2 wire-reinforced fenestrations for coronary artery stenting. The TAVR valve is sutured into an appropriately sized TEVAR graft. The coronary fenestrations are made in the TEVAR graft based on computed tomography angiography measurements. The Endo-Bentall device is then resheathed within the TEVAR delivery system, advanced via femoral access, and deployed during rapid pacing. If persistent endoleak is present after device deployment, the coronary ostia are accessed and stented. No cardiopulmonary support is required. RESULTS: Five patients with prohibitive risk (mean age, 79 years; 4 with type A dissection and 1 with an aortic root aneurysm) underwent Endo-Bentall repair between November 2022 and October 2023. Severe aortic insufficiency was present in 2 patients preoperatively. The median back table modification time was 120 minutes (range, 55-150 minutes). The Endo-Bentall device was successfully implanted in all patients (100%). Two patients required concomitant total endoarch repair. In-hospital mortality was 0%. No patient experienced postoperative stroke. Three patients needed coronary stenting, and 1 patient required permanent pacemaker insertion. On follow-up computed tomography scan (at a median of 172 days; range, 63-368 days), no patient had a type 1a endoleak. No aortic insufficiency was present on follow-up transthoracic echocardiography. CONCLUSIONS: Endo-Bentall repair using a single-stage valve-carrying conduit is feasible and effective, with encouraging early outcomes for highly selected patients with aortic root dissection or aneurysm who are considered not candidates for operation. Long-term follow-up data are needed to assess the persistence of the seal and ongoing durability of this novel technique.
引用
- Ghoreishi M, Shah A, Chahal D, et al. Endo-Bentall repair: Early results and feasibility of a physician-constructed Endo-Bentall device. J Thorac Cardiovasc Surg. 2025. PMID: 39824346. doi:10.1016/j.jtcvs.2024.11.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。